Transparent and Flexible Composite Films with Excellent Electromagnetic Interference Shielding and Thermal Insulating Performance.

As the working environment becomes more complex, the visualization of windows in electronic devices increasingly requires transparent and flexible electromagnetic interference (EMI) shielding films. There is a need for materials with EMI shielding properties, while maintaining excellent high light transmission and good thermal insulation. However, the preparation of such multifunctional materials remains challenging due to the respective mechanisms of action of the different properties. Herein, a multilayer structure strategy is proposed to fabricate transparent and flexible indium tin oxide (ITO)/silver nanowire (AgNW) composite films, achieving a multifunctional integration of high light transmission, strong EMI shielding, and good thermal insulation properties of the composite films. Simultaneously, the layered structure was designed and the potential optimization mechanism of the EMI shielding performance of the composite film was analyzed, providing great flexibility for the preparation of transparent composite films. The combination of excellent EMI shielding performance, outstanding near-infrared shielding performance, and high light transmittance makes the ITO/AgNW (IA) composite films promising for abundant potential applications.

Efficacy and Safety of Anti-Interleukin-5 Therapies in Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

INTRODUCTION: The efficacy and safety of benralizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) remain unresolved, and relevant meta-analyses are lacking. Additionally, mepolizumab has been evaluated in far fewer patients, and the evidence is unclear. We conducted a meta-analysis to identify evidence gaps that will guide future investigation of therapies targeting interleukin (IL)-5 signaling (anti-IL-5Rα or anti-IL-5) for CRSwNP. METHODS: We performed a systematic review and meta-analysis that were registered with PROSPERO (No. CRD42021276867). A comprehensive search was performed in PubMed, Embase, Web of Science, and the Cochrane Library on September 2, 2021. Only randomized controlled trials (RCTs) assessing anti-IL-5 treatments (anti-IL-5Rα or anti-IL-5) in adult patients for CRSwNP were included. RESULTS: Seven RCTs with 799 patients evaluating the efficacy and safety of treatments targeting IL-5 pathway (benralizumab [anti-IL-5Rα], mepolizumab, and reslizumab [anti-IL-5]) were included. The overall pooled meta-analysis showed that anti-IL-5 treatments were associated with a significantly better nasal polyp score (weighted mean difference [WMD]: -0.71; 95% confidence interval [CI]: [-0.87, -0.55]; p < 0.00001). Anti-IL-5 treatments were associated with a significantly better nasal congestion score (WMD: -1.73; 95% CI: [-2.29, -1.16]; p < 0.00001). Anti-IL-5 treatments were associated with a significantly better Sino-Nasal Outcome Test (SNOT-22) score (WMD: -11.30; 95% CI: [-14.77, -7.83]; p < 0.00001). The overall pooled meta-analysis showed that anti-IL-5 treatments were associated with a significantly better University of Pennsylvania Smell Identification Test (UPSIT) score (WMD: 2.09; 95% CI: [0.42, 3.77]; p = 0.01). Anti-IL-5 treatments significantly reduced the loss of smell score in the overall pooled meta-analysis (WMD: -1.38; 95% CI: [-1.97, -0.79]; p < 0.00001). In the overall pooled meta-analysis, anti-IL-5 treatments showed no difference with the placebo in the risk of adverse events (AEs; risk ratio [RR]: 1.01; 95% CI: [-0.93, 1.09]; p = 0.83) and serious AEs (SAEs; RR: 0.73; 95% CI: [0.40, 1.34]; p = 0.32). CONCLUSION: This systematic review and meta-analysis identified that anti-IL-5 treatments significantly improved the size of nasal polyps, health-related quality of life, and sense of smell in moderate to severe CRSwNP, and they were safe and well tolerated.

Expression of CD27 and CD28 on γδ T cells from the peripheral blood of patients with allergic rhinitis.

The costimulatory receptors CD27 and CD28 have pivotal and non-redundant roles in the activation and differentiation of γδ T-cells. However, the roles of CD27 and CD28 on γδ T-cells in allergic rhinitis (AR) have remained elusive. The aim of the present study was to investigate the expression of CD27 and CD28 on γδ T cells in patients with AR. Peripheral blood mononuclear cells from 14 patients with AR and 12 healthy subjects were isolated and analyzed by flow cytometry to determine the percentage of γδ T cells and regulatory T cells (Tregs), and the expression of IFN-γ, IL-17A, CD27 and CD28 on γδ T cells. The correlations between the expression of CD27 and CD28, and the percentages of IFN-γ+ and IL-17A+ γδ T-cell subsets and Tregs in AR were analyzed. It was observed that the percentages of γδ T cells, and the IL-17A+, CD27-CD28+ and CD27-CD28- γδ T-cell subsets were significantly increased, while the percentages of Tregs and IFN-γ+ and CD27+CD28+ γδ T-cell subsets were significantly decreased in AR. Of note, the percentage of CD27+CD28+ γδ T-cell subsets was positively correlated with that of the IFN-γ+ γδ T-cell subset and the percentage of the CD27-CD28+ γδ T-cell subset was positively correlated with that of the IL-17A+ γδ T-cell subset. Furthermore, the percentages of γδ T cells and the CD27-CD28+ γδ T-cell subset were both negatively correlated with that of Tregs. Therefore, the results of the present study indicate that CD27 and CD28 may be the key signals for activation of different γδ T-cell subsets and may contribute to the immune regulatory function of γδ T cells in the peripheral blood of patients with AR.

[Multiple factors quantitative analysis on middle ear function in primarily diagnosed patients with nasopharyngeal carcinoma].

OBJECTIVE: To explore the ways of quantitative and objective evaluation for analyzing the multiple influence factors on middle ear function in the patients with primarily diagnosed NPC, and to analyze the influence factors of middle ear function in the patients with primarily diagnosed nasopharyngeal carcinoma (NPC). METHOD: Three hundred and twenty cases (320 ears) of primarily diagnosed NPC patients were examinated with electric otoscope, acoustic immittance measurement, pure tone audiometry, nasopharynx and middle ear CT or MRI scanning, eustachian tube function examination, and electronic nasopharyngoscope. A series of quantitative methods, as the influence factors including T stage, clinical stage, location, diffusion type and form of tumor, eustachian tube function, pharynx mouth shape, imaging extension (nasal, skull base, pharyngeal recess, parapharyngeal space, tensor veli palatini muscle, levator veli palatini and so on), were used to evaluate the middle ear function. SPSS 13.0 was used to anlyze the single and multiple factors in statistics. RESULT: T stage, clinical stage, location, diffusion type, and form of tumor, pharynx mouth shape, imaging extension (nasal, skull base, pharyngeal recess, parapharyngeal space, tensor veli palatini muscle, levator veli palatini) were the single influence factors on the function of middle ear in primarily diagnosed NPC patients. The gender, age, pathological types, N staging and M staging of NPC patients primarily diagnosed had no effect on middle ear function. The multple factors analysis showed that T stage, tumor location, the function of eustachian tube, tensor veli palatini muscle invasion, and skull base invasion were independent factor of affecting the middle ear function on primarily diagnosed NPC patients. CONCLUSION: In this study, the influence factors of middle ear function with primarily diagnosed NPC were related to T stage, location of tumor, the function of eustachian tube, tensor veli palatini muscle invasion, skull base invasion, otitis media and quantitative criteria. The way of quantitative analysis could be used to evaluate objectively the middle ear function in patients with primarily diagnosed NPC.